Oncology Research and Treatment
Journal Abbreviation: Oncol Res Treat
ISSN: 2296-5270
eISSN: 2296-5262
Publisher: Karger Publishers
Publications (237)
Impact of comorbidities on outcome with second and further line TKI treatment in patients with chronic myeloid leukemia (2019)
Yildirim-Zuemruet G, Kohlbrenner K, Hehlmann R, Fabarius A, Baerlocher GM, Krause S, Burchert A, et al.
Conference contribution
Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model (2019)
Kong W, Sender S, Sekora A, Ma Y, Ruetgen B, Nolte I, Taher L, et al.
Conference contribution
Automated whole exome sequencing analysis pipeline to support a molecular tumor board (2019)
Metzger P, Hess M, Jaravine , Boeker M, Christoph J, Unberath P, Busch H, et al.
Conference contribution
The relevance of cancer related fatigue in neuroendocrine neoplasia patients (2019)
Banz S, Mellar K, Letsch A, Scheibenbogen C, Pavel ME, Grabowski P
Conference contribution
Expression of Prostate-specific Membrane Antigen (PSMA) in papillary renal cell carcinoma (pRCC) (2019)
Zschaebitz S, Erlmeier F, Stoehr C, Polifka I, Schrader AJ, Hartmann A, Ivanyi P, Steffens S
Conference contribution
Disrupted osteoclast differentiation results in myelodysplasia (2019)
Kazianka L, Kornauth C, Van Der Kouwe E, Schmetterer K, Heller G, Marculescu R, Bach C, et al.
Conference contribution
Loss of TP53 modifies the quantity and protein load of extracellular vesicles in leukemic B-cells and influences functional crosstalk within the tumor microenvironment (2019)
Izquierdo-Alvarez E, Vorholt D, Wiederstein J, Lobastova L, Blakemore SJ, Krueger M, Hansen H, et al.
Conference contribution
Blood counts in adults and elderly individuals (2019)
Zierk J, Krebs A, Rauh M, Metzler M, Parsch H, Strasser E, Krause S
Conference contribution
A human CD22 transgenic, myc-driven lymphoma model to test effects of targeted therapies on lymphoma immune microenvironment in immunecompetent mice (2019)
Wagner F, Brandl C, Petkovic S, Emmerich C, Nitschke L, Mackensen A, Müller F
Conference contribution
2-Deoxyglucose induced unfolded protein response enhances efficacy of immunotoxin Moxetumomab pasudotox against lymphoma and leukemia xenografts (2019)
Wagner F, Meier C, Krumbholz M, Metzler M, Mackensen A, Müller F
Conference contribution